These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6454034)
1. Hypothesis: do phases of immunosuppression during a Mycobacterium leprae infection determine the leprosy spectrum? Stoner GL Lepr Rev; 1981 Mar; 52(1):1-10. PubMed ID: 6454034 [No Abstract] [Full Text] [Related]
2. The influence of immunosuppression and immunodeficiency on infections with leprosy and tuberculosis. Strickland NH Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):86-100. PubMed ID: 2987376 [No Abstract] [Full Text] [Related]
3. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. Rada EM; Convit J; Ulrich M; Gallinotto ME; Aranzazu N Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084 [TBL] [Abstract][Full Text] [Related]
4. Learning from leprosy: a perspective on immunology and the Third World. Bloom BR J Immunol; 1986 Jul; 137(1):i-x. PubMed ID: 2423599 [No Abstract] [Full Text] [Related]
5. Towards a vaccine against leprosy. Sengupta U Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444 [No Abstract] [Full Text] [Related]
6. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
7. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
13. Investigations related to the development of a leprosy vaccine. Convit J; Aranzazu N; Ulrich M; Zúñiga M; de Aragón ME; Alvarado J; Reyes O Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):531-9. PubMed ID: 6231259 [No Abstract] [Full Text] [Related]
14. [The genetic susceptibility to leprosy in humans]. Lagrange PH; Abel L Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289 [TBL] [Abstract][Full Text] [Related]
15. Natural history of leprosy--aspects relevant to a leprosy vaccine. Fine PE Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):553-5. PubMed ID: 6368419 [No Abstract] [Full Text] [Related]
16. Immunology of human leprosy--current status. Nath I Lepr Rev; 1983 Jun; Spec No():31-45. PubMed ID: 6224992 [No Abstract] [Full Text] [Related]
17. Prospects for new generation vaccines for leprosy: progress, barriers, and future strategies. Watson JD Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):834-43. PubMed ID: 2681465 [No Abstract] [Full Text] [Related]
18. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740 [TBL] [Abstract][Full Text] [Related]
19. Host-parasite interaction in relation to leprosy. Mahadevan PR Indian J Lepr; 1985; 57(2):239-57. PubMed ID: 2934487 [No Abstract] [Full Text] [Related]